ABBV 241018 185.00C (ABBV241018C185000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ABBV241018C185000

Watchlist

5.72
-3.58-38.49%

15min DelayClose Oct 16 16:00 ET

5.83High5.00Low

Intraday

5D
Daily

News

Bernstein starts to focus on US pharmaceutical stocks, giving Eli Lilly and Co (LLY.US) and others a "outperforming the large cap" rating.
Bernstein starts covering Eli Lilly and Co (LLY.US), Gilead Sciences (GILD.US), and Amgen (AMGN.US), all with an "outperform" rating.
Zhitong Finance00:02 ET
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Seeking Alpha17:05 ET
AbbVie Hits 9-week Low
Trading EconomicsOct 16 09:32 ET
Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight Into Patient Perception
PR NewswireOct 16 08:00 ET
Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $205
Moomoo NewsOct 16 05:33 ET · Ratings
Lupin Launches First Generic of Pred Forte(r) in US
MT NewswiresOct 15 02:54 ET

Comments

Bellaah

Oct 9 14:05

$AbbVie (ABBV.US)$ 200

Moomoo News Global

Sep 19 07:24

Columns Will Rate Cuts Boost the Stock Market? A Global Equity Investment Guide

The Federal Reserve on Wednesday implemented its first rate cut in over four years, reducing the benchmark rate by 50 basis points to a range of 4.75%-5%.
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...

Aggressive 50bp rate cut: How long will the market frenzy last?

In One Chart

Aug 22 07:58

Columns In One Chart | Wall Street Eyes New Sectors for the Next Stock Market Surge

Recent data shows that defensive sectors like utilities, consumer defensive, and healthcare have outperformed the information technology sector over the past month, reaching 52-week highs.
Notably, several stocks within these sectors have shown exceptional performance. Pharmaceutical giants with market values in the hundreds of billions, such as $Eli Lilly and Co (LLY.US)$, $Thermo Fisher Scientific (TMO.US)$, $AbbVie (ABBV.US)$, and ...

Payrolls revised downward: Where are U.S. stocks headed?

272

111

IPELove

Aug 17 00:39

$AbbVie (ABBV.US)$ too strong 💪 waiting to buy in at $180

BuyHighSellLow000

Aug 15 20:02

new user, mostly investing in dividend paying stocks

finally green again after the last few weeks. still don't know what I'm doing, but trying to learn

Share Your Profit/Loss